PERSISTENT ATRIAL FIBRILLATION AFTER CATHETER ABLATION IN HUMAN IMMUNODEFICIENCY VIRUS TYPE‐1 POSITIVE PATIENTS

PERSISTENT ATRIAL FIBRILLATION AFTER CATHETER ABLATION IN HUMAN IMMUNODEFICIENCY VIRUS TYPE‐1 POSITIVE PATIENTS

Other: Electrophysiology A 35-year-old with HIV-1 on 800 mg Darunavir, 150 mg Cobicistat, 200 mg Emtricitabine, and 10 mg Tenofovir Alafenamide presented with palpitations. Initial vitals significant for 120-140 beats per minute. 12-lead electrocardiogram showed atrial flutter with variable A-V bloc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of preventive cardiology 2024-09, Vol.19, p.100830, Article 100830
1. Verfasser: Navajas, Sophia
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Other: Electrophysiology A 35-year-old with HIV-1 on 800 mg Darunavir, 150 mg Cobicistat, 200 mg Emtricitabine, and 10 mg Tenofovir Alafenamide presented with palpitations. Initial vitals significant for 120-140 beats per minute. 12-lead electrocardiogram showed atrial flutter with variable A-V block. Patient's troponin I was
ISSN:2666-6677
2666-6677
DOI:10.1016/j.ajpc.2024.100830